Selling into a wave of new capacity being built by others: management describes its customers' own build-out spending as
The model's full reasoning — Q4 2017 call → NOWe need to determine if management explains current momentum and near-term trajectory chiefly by pointing to a wave of new building/equipping/capacity-creation by other parties, where the company already supplies part of what those parties must buy, and the wave is early/intensifying. Let's analyze the transcript. The company is Acadia Healthcare, a behavioral healthcare provider. They operate facilities. They talk about adding beds to their own facilities, joint ventures, de novos. That's their own capacity expansion, not others building. They mention the Cures Act and opioid funding. They say money goes through states, and they have early successes in three states where the Cures Act is being used to give better treatment. They think other states will follow. They have lobbyists. They can't quantify yet. This is about funding for treatment, not necessarily building new capacity by others. It's more about demand and funding. They talk about UK operations, NHS transition, agency labor, etc. Not about others building. They talk about joint ventures with hospitals. The hospitals are closing their psych units and using the joint venture. That's not others building new capacity; it's them partnering. They mention the opioid epidemic and potential acquisitions. But no clear wave of others building. The question asks: does management explain current momentum and near-term trajectory chiefly by pointing to a wave of new building, equipping, or capacity-creation being undertaken by other parties? The company supplies part of what those parties must buy. Here, the company is a healthcare provider. Who are the other parties? Possibly the government building treatment capacity? But they are not building; they are funding. Or hospitals building? Not really. Management's remarks focus on their own bed additions, their own de novos, their own joint ventures. That's their own capacity expansion, not others. They mention the Cures Act money flowing to states, but that's funding for treatment, not construction. They say "the money will go through the state and they will find a way to get it for treatment." That's not about building new facilities by others. They also mention the opioid epidemic and potential acquisitions, but that's not a build-out. Thus, the answer is NO. The company's momentum is driven by its own expansion, not by others building.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| AES | The AES Corporation | Q1 2024 | 2024-05-03 | C+ |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| RDCM | RADCOM Ltd. | Q4 2023 | 2024-01-31 | A |
| TEL | TE Connectivity Ltd. | Q4 2023 | 2023-11-01 | B |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| ADSE | ADS-TEC Energy PLC | Q4 2021 | 2022-04-28 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| IPGP | IPG Photonics Corporation | Q3 2021 | 2021-11-02 | C |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| ATI | Allegheny Technologies Incorporated | Q1 2018 | 2018-04-24 | B |
TEL · Q4 2023 → YESThe question is about whether management explains the company's current momentum and near-term trajectory by pointing to a wave of new building or capacity-creation by others, that's early or intensif...YES The transcript shows management framing the company's momentum chiefly through a wave of external capacity creation: EV production growth (40% in 2023, expected continued growth next year, with Asia as driver), renewable energy adoption (wind/solar), and AI/cloud applications. They describe others (OEMs, installers 3rd parties) building new productive capability—new EV platforms, renewable sites, AI clusters—while TE already supplies into it via content outperformance and early ramps. Current business is real (sequential order growth, $1.3B pipeline, $100M+ incremental AI revenue). The wave is early/intensifying 2024–2025 (3–4 year programs, more phases ahead, destocking normalizing). This is presented as the primary secular driver offsetting cyclical weakness, not just consumption or pricing. Other elements (destocking, FX) are secondary. Thus all three conditions are met in substance.
ATI · Q1 2018 → YESThe question is about whether management explains the company's current momentum and near-term trajectory by pointing to a wave of new building or capacity-creation by other parties, like customers, t...YES The transcript shows management attributing HPMC momentum chiefly to the "ongoing production ramp of next-generation jet engines at all of our major engine OEM customers" and the "industry is currently in the early phases of a multi-year production expansion." This describes OEMs creating new productive capacity through rate ramps and build growth for next generation engines. Management confirms current business from this wave with "next-generation product sales reached 48% of total jet engine product sales" and "65% increase in next-generation product sales," plus "seventh consecutive quarter of year-over-year margin expansion.
RDCM · Q4 2023 → YESThe question is about whether management explains the company's current momentum and near-term trajectory by pointing to a wave of new building, equipping, or capacity-creation by other parties (custo...YES The transcript shows management framing 2024 momentum around operators’ ongoing 5G standalone network build-outs (new productive capacity being created by customers), with RADCOM already supplying assurance software to those projects and the wave described as still early and accelerating. All three conditions are met in Eyal Harari’s prepared remarks and Q&A.